Sort
35,931 grants matching “parkinsons”
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
$1,032,827Mark Cookson · National Institute On Aging · ZIA · FY2021 · AG
SPLICE VARIANT BIOMARKERS FOR PARKINSON'S DISEASE
$1,032,778Rosalind Franklin University Of Medicine & Science · · FY2013 · Department of Defense
In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia
$1,031,916William E Klunk · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · AG
The Functional Role and Neural Basis of Rapid Turns in Olfactory Search Behavior
$1,030,838Michael H Dickinson · California Institute Of Technology · R01 · FY2025 · NS
New Mexico Alzheimer's Disease Research Center
$1,030,652Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P20 · FY2021 · AG
Imaging of Neuropsychiatric Disorders with Developmental and Genetic Mechanisms
$1,029,004Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2019 · MH
Determining the Fate of Transmembrane Proteins
$1,028,830Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Prospective studies on Parkinson's disease
$1,028,725Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Subthalamic and corticosubthalamic coding of speech production
$1,028,607Robert Mark Richardson · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · NS
DSU Sub-Project 1
$1,028,338Harb S. Dhillon · Delaware State University · P20 · FY2016 · GM
Genetic Analysis of Dementia Disorders Neuropathologically Between Alzheimer's and Parkinson's Disease
$1,027,808Andrew Singleton · National Institute On Aging · ZIA · FY2019 · AG
OREGON ALZHEIMER DISEASE CENTER
$1,027,641Oregon Health And Science University · P30 · FY2001 · AG
Role of Microglia somatic variants in Neurodegenerative diseases
$1,027,639Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2020 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2022 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2018 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2019 · NS
An iPSC based platform for functionally assessing genetic and environmental risk
$1,026,973Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2014 · NS
A Randomized Recruitment Intervention
$1,026,949Sally W Vernon · University Of Texas Hlth Sci Ctr Houston · U24 · FY2015 · MD
Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases
$1,026,770Christophe Hp Morisseau · University Of California At Davis · R35 · FY2025 · ES
Clinical Pathological Study of Cognitive Impairment in Essential Tremor
$1,026,424Elan D Louis · Ut Southwestern Medical Center · R01 · FY2022 · NS
Clinical Pathological Study of Cognitive Impairment in Essential Tremor
$1,026,412Elan D Louis · Ut Southwestern Medical Center · R01 · FY2023 · NS
Clinical Pathological Study of Cognitive Impairment in Essential Tremor
$1,026,260Elan D Louis · Ut Southwestern Medical Center · R01 · FY2021 · NS
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
$1,024,654Paul B Rosenberg · Johns Hopkins University · R01 · FY2016 · AG
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers In Sleep Dysregulation and Repair
$1,023,821Aviva Abosch · University Of Nebraska Medical Center · UH3 · FY2021 · NS
Neurons, Vessels and Voxels: Multi-modal Imaging of Layer Specific Signals
$1,023,283Kamil Ugurbil · University Of Minnesota · R01 · FY2016 · MH